NMO-IgG binds to AQP4 on astrocytes, then induces complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity (ADCC), and finally leads to blood-brain barrier disruption, demyelination, and neuronal injury [38]. Here, AQP4 is linked to neuromyelitis optica.